3."High normal" thyroid stimulating hormone: does it matter?.
The Korean Journal of Internal Medicine 2013;28(2):162-164
No abstract available.
Female
;
Humans
;
Metabolic Syndrome X/*blood
;
Thyrotropin/*blood
4.Uterine alveolar rhabdomyosarcoma in an elderly patient manifesting extremely poor prognosis; a rare subtype of rhabdomyosarcoma
Haewon CHOI ; Hyunji LEE ; Hee Sun KIM ; Jung Yeol HAN ; Kyoung-Chul CHUN
Obstetrics & Gynecology Science 2021;64(2):234-238
Alveolar rhabdomyosarcoma (ARMS) arising in the corpus uteri is an extremely rare condition with exceptionally rapid progression and poor prognosis. Furthermore, ARMS is primarily diagnosed in the pediatric population. Due to rarity of the disease, there are no standard treatment guidelines. A 90-year-old woman was presented with a huge pelvic mass causing dyspnea and abdominal distension. The patient underwent debulking surgery and was diagnosed with uterine ARMS by fresh specimen biopsy. Despite intensive postoperative care, the patient died on the eighth postoperative day. Here, we report a case of uterine ARMS that will add to our understanding of this exceptionally rare type of tumor.
5.Uterine alveolar rhabdomyosarcoma in an elderly patient manifesting extremely poor prognosis; a rare subtype of rhabdomyosarcoma
Haewon CHOI ; Hyunji LEE ; Hee Sun KIM ; Jung Yeol HAN ; Kyoung-Chul CHUN
Obstetrics & Gynecology Science 2021;64(2):234-238
Alveolar rhabdomyosarcoma (ARMS) arising in the corpus uteri is an extremely rare condition with exceptionally rapid progression and poor prognosis. Furthermore, ARMS is primarily diagnosed in the pediatric population. Due to rarity of the disease, there are no standard treatment guidelines. A 90-year-old woman was presented with a huge pelvic mass causing dyspnea and abdominal distension. The patient underwent debulking surgery and was diagnosed with uterine ARMS by fresh specimen biopsy. Despite intensive postoperative care, the patient died on the eighth postoperative day. Here, we report a case of uterine ARMS that will add to our understanding of this exceptionally rare type of tumor.
6.Risk Factors for Progression to Postpartum Diabetes Mellitus and Perinatal Complications in Women with Gestational Diabetes Mellitus.
Su Jeong KIM ; Hyunji CHUN ; Eun Hee JANG ; Joune Seup LEE ; Meekyoung KIM ; Ki Hyun BAEK ; Ki Ho SONG ; Hyuk Sang KWON
Journal of Korean Diabetes 2014;15(2):116-123
BACKGROUND: Gestational diabetes mellitus (GDM) is a hyperglycemic condition caused by increased insulin resistance and impaired insulin secretion during pregnancy. It is known to be temporary, but it can cause perinatal complications in the mother and baby. Additionally, it may progress to type 2 diabetes mellitus (T2DM). In the present study, we evaluated the risk factors for complications and progression to T2DM in patients with GDM. METHODS: The study included 130 pregnant women who were diagnosed with GDM at gestational weeks 24-28 in 2011. Body mass index and the levels of glucose, total cholesterol, lipoproteins, and coagulation factors (von Willebrand factor and plasminogen activator inhibitor-1) were assessed in all patients. RESULTS: The level of high-density lipoprotein (HDL) was significantly lower and the triglyceride/HDL ratio and coagulation factor levels were significantly higher in the group of patients with perinatal complications compared to those in the group of patients without complications. After delivery, the level of HDL was lower and the value of homeostasis model assessment of insulin resistance (HOMA-IR) was higher in women with impaired glucose metabolism compared to those in women with normal glucose metabolism. In logistic regression analysis, perinatal complications were independently associated with HDL and PAI-1 levels (OR = 0.929 and 1.101, respectively). CONCLUSION: The findings of our study show that the levels of HDL and coagulation factors are notable risk factors of perinatal complications. Additionally, we showed that lower HDL level may influence the progression to T2DM. Large-scale population studies are needed to verify our findings.
Blood Coagulation Factors
;
Body Mass Index
;
Cholesterol
;
Diabetes Mellitus*
;
Diabetes Mellitus, Type 2
;
Diabetes, Gestational*
;
Female
;
Glucose
;
Homeostasis
;
Humans
;
Insulin
;
Insulin Resistance
;
Lipoproteins
;
Lipoproteins, HDL
;
Logistic Models
;
Metabolism
;
Mothers
;
Plasminogen Activator Inhibitor 1
;
Plasminogen Activators
;
Postpartum Period*
;
Pregnancy
;
Pregnant Women
;
Risk Factors*
;
von Willebrand Factor